These innovative therapies, including copyright , belong to a category of drugs called GLP-1 receptor agonists . Primarily intended for treating diabetes mellitus , they work by encouraging the organism to produce adequate insulin production and curbing excessive sugar levels. Beyond diabetes, their potential to encourage weight management has cont